國家衛生研究院 NHRI:Item 3990099045/1156
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 956626      線上人數 : 825
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/1156


    題名: Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV
    作者: Hsu, JTA;Kuo, CJ;Hsieh, HP;Wang, YC;Huang, KK;Lin, CPC;Huang, PF;Chen, X;Liang, PH
    貢獻者: Division of Biotechnology and Pharmaceutical Research
    摘要: 3C-like (3CL) protease is essential for the life cycle of severe acute respiratory syndrome-coronavirus (SARS-CoV) and therefore represents a key anti-viral target. A compound library consisting of 960 commercially available drugs and biologically active substances was screened for inhibition of SARS-CoV 3CL protease. Potent inhibition was achieved using the mercury-containing compounds thimerosal and phenylmercurie acetate, as well as hexachlorophene. As well, 1-10 muM of each compound inhibited viral replication in Vero E6 cell culture. Detailed mechanism studies using a fluorescence-based protease assay demonstrated that the three compounds acted as competitive inhibitors (Ki = 0.7, 2.4, and 13.7 muM for phenylmercuric acetate, thimerosal, and hexachlorophene, respectively). A panel of metal ions including Zn2+ and its conjugates were then evaluated for their anti-3CL protease activities. Inhibition was more pronounced using a zinc-conjugated compound (1-hydroxypyridine-2-thione zinc; K-i = 0.17 muM) than using the ion alone (K-i = 1.1 muM). (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
    關鍵詞: Biochemistry & Molecular Biology;Biophysics;Cell Biology
    日期: 2004-09-10
    關聯: FEBS Letters. 2004 Sep;574(1-3):116-120.
    Link to: http://dx.doi.org/10.1016/j.febslet.2004.08.015
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0014-5793&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000224041600021
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=4444368730
    顯示於類別:[徐祖安] 期刊論文
    [謝興邦] 期刊論文
    [陳新(2002-2015)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    000224041600021.pdf124KbAdobe PDF611檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋